These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36464219)

  • 1. Vitiligo: An immune disease and its emerging mesenchymal stem cell therapy paradigm.
    Zhang M; Xia T; Lin F; Yu J; Yang Y; Lei W; Zhang T
    Transpl Immunol; 2023 Feb; 76():101766. PubMed ID: 36464219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors.
    Faraj S; Kemp EH; Gawkrodger DJ
    Clin Exp Immunol; 2022 Jan; 207(1):27-43. PubMed ID: 35020865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repigmentation by combined narrow‑band ultraviolet B/adipose‑derived stem cell transplantation in the mouse model: Role of Nrf2/HO‑1‑mediated Ca
    Bian Y; Yu H; Jin M; Gao X
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34751412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitiligo: interplay between oxidative stress and immune system.
    Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R
    Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection.
    Xie B; Zhu Y; Shen Y; Xu W; Song X
    Expert Opin Ther Targets; 2023 Mar; 27(3):189-206. PubMed ID: 36947026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells promote human melanocytes proliferation and resistance to apoptosis through PTEN pathway in vitiligo.
    Zhu L; Lin X; Zhi L; Fang Y; Lin K; Li K; Wu L
    Stem Cell Res Ther; 2020 Jan; 11(1):26. PubMed ID: 31941556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-derived microRNAs: emerging players in vitiligo.
    Li W; Pang Y; He Q; Song Z; Xie X; Zeng J; Guo J
    Front Immunol; 2024; 15():1419660. PubMed ID: 39040109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
    Boukhedouni N; Martins C; Darrigade AS; Drullion C; Rambert J; Barrault C; Garnier J; Jacquemin C; Thiolat D; Lucchese F; Morel F; Ezzedine K; Taieb A; Bernard FX; Seneschal J; Boniface K
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-seq Reveals Dysregulation of Novel Melanocyte Genes upon Oxidative Stress: Implications in Vitiligo Pathogenesis.
    Sastry KS; Naeem H; Mokrab Y; Chouchane AI
    Oxid Med Cell Longev; 2019; 2019():2841814. PubMed ID: 31871544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo Pathogenesis and Emerging Treatments.
    Rashighi M; Harris JE
    Dermatol Clin; 2017 Apr; 35(2):257-265. PubMed ID: 28317534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated autophagy increased melanocyte sensitivity to H
    He Y; Li S; Zhang W; Dai W; Cui T; Wang G; Gao T; Li C
    Sci Rep; 2017 Feb; 7():42394. PubMed ID: 28186139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
    Xie H; Zhou F; Liu L; Zhu G; Li Q; Li C; Gao T
    J Dermatol Sci; 2016 Jan; 81(1):3-9. PubMed ID: 26387449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines: the yin and yang of vitiligo pathogenesis.
    Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
    Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.
    Wang Y; Li S; Li C
    Med Sci Monit; 2019 Feb; 25():1017-1023. PubMed ID: 30723188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway.
    Ma J; Li S; Zhu L; Guo S; Yi X; Cui T; He Y; Chang Y; Liu B; Li C; Jian Z
    Free Radic Biol Med; 2018 Dec; 129():492-503. PubMed ID: 30342186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
    Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
    J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo.
    Jian Z; Li K; Song P; Zhu G; Zhu L; Cui T; Liu B; Tang L; Wang X; Wang G; Gao T; Li C
    J Invest Dermatol; 2014 Aug; 134(8):2221-2230. PubMed ID: 24662764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency.
    Zhou MN; Zhang ZQ; Wu JL; Lin FQ; Fu LF; Wang SQ; Guan CP; Wang HL; Xu A
    PLoS One; 2013; 8(4):e60254. PubMed ID: 23577097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo.
    Dell'anna ML; Picardo M
    Pigment Cell Res; 2006 Oct; 19(5):406-11. PubMed ID: 16965269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.